Safety and efficacy of vigabatrin and carbamazepine. CPMP. The Committee for Proprietary Medicinal Products.
Elferink
A J
AJ
Toivonen
M
M
van Bronswijk
H
H
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000627:therapeutic use*; D002648:Child; D004828:Epilepsies, Partial / Q000188:drug therapy*; D006801:Humans; D018570:Risk Assessment; D020888:Vigabatrin / Q000009:adverse effects*; D014794:Visual Fields / Q000187:drug effects
D000927:Anticonvulsants; D002220:Carbamazepine; D020888:Vigabatrin